Zero to Hero? Scope 3 Emissions – A Strategic Imperative for Pharma Companies Verena Ahnert Read more
Executive Insights Contract/Pharma Services Key Trends for CDMOs Partnering With Cell Therapy Developers July 11, 2024
Case Study Biotech and Pharmaceuticals Reimbursement Assessment for a Therapy for Hemodialysis Patients May 3, 2024 A biopharmaceutical company with a novel treatment of chronic kidney disease-associated pruritus asked L.E.K. to assess the potential risk of bundling of…
Smart Chart Mental and Behavioral Health Look Forward to Transforming the Patient Journey in Mental Health December 14, 2023
Article Life Sciences & Pharma Digital Transformation in the Pharmaceutical Industry September 28, 2023
Podcast Life Sciences & Pharma Access, Efficacy and Collaboration: Unlocking the Potential of Gene Therapies September 13, 2023